Molecular genetics of human cancer predisposition and progression

Webster K. Cavenee, Heidi J. Scrable, C. David James

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The development of human cancer is generally thought to entail a series of events that cause a progressively more malignant phenotype. Such a hypothesis predicts that tumor cells of the ultimate stage will carry each of the events, cells of the penultimate stage will carry each of the events less the last one and so on. A dissection of the pathway from a normal cell to a fully malignant tumor may thus be viewed as the unraveling of a nested set of aberrations. In experiments designed to elucidate these events we have compared genotypic combinations at genomic loci defined by restriction endonuclease recognition site variation in normal and tumor tissues from patients with various forms and stages of cancer. The first step, inherited predisposition, is best described for retinoblastoma in which a recessive mutation of a locus residing in the 13q14 region of the genome is unmasked by aberrant, but specific, mitotic chromosomal segregation. Similar mechanisms involving the distal short arm of chromosome 17 are apparent in astrocytic tumors and the events are shared by cells in each malignancy state. DNA sequencing indicates that these events accomplish the homozygosis of mutant alleles of the p53 gene. Copy number amplification of the epidermal growth factor receptor gene occurs in intermediate and late-stage tumors whereas loss of heterozygosity for loci on chromosome 10 is restricted to the ultimate stage, glioblastoma multiforme. These results suggest a genetic approach to defining degrees of tumor progression and the locations of genes involved in the pathway as a prelude to their molecular isolation and characterization.

Original languageEnglish (US)
Pages (from-to)199-202
Number of pages4
JournalMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
Volume247
Issue number2
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Molecular Biology
Neoplasms
erbB-1 Genes
Chromosomes, Human, Pair 10
Chromosomes, Human, Pair 17
Retinoblastoma
Loss of Heterozygosity
DNA Restriction Enzymes
p53 Genes
Human Development
Glioblastoma
DNA Sequence Analysis
Dissection
Alleles
Genome
Phenotype
Mutation
Genes

Keywords

  • Cancer, human progression of
  • Cancer, human, predisposition to
  • Genetics, molecular

ASJC Scopus subject areas

  • Molecular Biology
  • Health, Toxicology and Mutagenesis

Cite this

Molecular genetics of human cancer predisposition and progression. / Cavenee, Webster K.; Scrable, Heidi J.; David James, C.

In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, Vol. 247, No. 2, 1991, p. 199-202.

Research output: Contribution to journalArticle

Cavenee, Webster K. ; Scrable, Heidi J. ; David James, C. / Molecular genetics of human cancer predisposition and progression. In: Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis. 1991 ; Vol. 247, No. 2. pp. 199-202.
@article{73f7f68fc3ab48e19d8523e1ba719db5,
title = "Molecular genetics of human cancer predisposition and progression",
abstract = "The development of human cancer is generally thought to entail a series of events that cause a progressively more malignant phenotype. Such a hypothesis predicts that tumor cells of the ultimate stage will carry each of the events, cells of the penultimate stage will carry each of the events less the last one and so on. A dissection of the pathway from a normal cell to a fully malignant tumor may thus be viewed as the unraveling of a nested set of aberrations. In experiments designed to elucidate these events we have compared genotypic combinations at genomic loci defined by restriction endonuclease recognition site variation in normal and tumor tissues from patients with various forms and stages of cancer. The first step, inherited predisposition, is best described for retinoblastoma in which a recessive mutation of a locus residing in the 13q14 region of the genome is unmasked by aberrant, but specific, mitotic chromosomal segregation. Similar mechanisms involving the distal short arm of chromosome 17 are apparent in astrocytic tumors and the events are shared by cells in each malignancy state. DNA sequencing indicates that these events accomplish the homozygosis of mutant alleles of the p53 gene. Copy number amplification of the epidermal growth factor receptor gene occurs in intermediate and late-stage tumors whereas loss of heterozygosity for loci on chromosome 10 is restricted to the ultimate stage, glioblastoma multiforme. These results suggest a genetic approach to defining degrees of tumor progression and the locations of genes involved in the pathway as a prelude to their molecular isolation and characterization.",
keywords = "Cancer, human progression of, Cancer, human, predisposition to, Genetics, molecular",
author = "Cavenee, {Webster K.} and Scrable, {Heidi J.} and {David James}, C.",
year = "1991",
doi = "10.1016/0027-5107(91)90015-G",
language = "English (US)",
volume = "247",
pages = "199--202",
journal = "Mutation Research",
issn = "1386-1964",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Molecular genetics of human cancer predisposition and progression

AU - Cavenee, Webster K.

AU - Scrable, Heidi J.

AU - David James, C.

PY - 1991

Y1 - 1991

N2 - The development of human cancer is generally thought to entail a series of events that cause a progressively more malignant phenotype. Such a hypothesis predicts that tumor cells of the ultimate stage will carry each of the events, cells of the penultimate stage will carry each of the events less the last one and so on. A dissection of the pathway from a normal cell to a fully malignant tumor may thus be viewed as the unraveling of a nested set of aberrations. In experiments designed to elucidate these events we have compared genotypic combinations at genomic loci defined by restriction endonuclease recognition site variation in normal and tumor tissues from patients with various forms and stages of cancer. The first step, inherited predisposition, is best described for retinoblastoma in which a recessive mutation of a locus residing in the 13q14 region of the genome is unmasked by aberrant, but specific, mitotic chromosomal segregation. Similar mechanisms involving the distal short arm of chromosome 17 are apparent in astrocytic tumors and the events are shared by cells in each malignancy state. DNA sequencing indicates that these events accomplish the homozygosis of mutant alleles of the p53 gene. Copy number amplification of the epidermal growth factor receptor gene occurs in intermediate and late-stage tumors whereas loss of heterozygosity for loci on chromosome 10 is restricted to the ultimate stage, glioblastoma multiforme. These results suggest a genetic approach to defining degrees of tumor progression and the locations of genes involved in the pathway as a prelude to their molecular isolation and characterization.

AB - The development of human cancer is generally thought to entail a series of events that cause a progressively more malignant phenotype. Such a hypothesis predicts that tumor cells of the ultimate stage will carry each of the events, cells of the penultimate stage will carry each of the events less the last one and so on. A dissection of the pathway from a normal cell to a fully malignant tumor may thus be viewed as the unraveling of a nested set of aberrations. In experiments designed to elucidate these events we have compared genotypic combinations at genomic loci defined by restriction endonuclease recognition site variation in normal and tumor tissues from patients with various forms and stages of cancer. The first step, inherited predisposition, is best described for retinoblastoma in which a recessive mutation of a locus residing in the 13q14 region of the genome is unmasked by aberrant, but specific, mitotic chromosomal segregation. Similar mechanisms involving the distal short arm of chromosome 17 are apparent in astrocytic tumors and the events are shared by cells in each malignancy state. DNA sequencing indicates that these events accomplish the homozygosis of mutant alleles of the p53 gene. Copy number amplification of the epidermal growth factor receptor gene occurs in intermediate and late-stage tumors whereas loss of heterozygosity for loci on chromosome 10 is restricted to the ultimate stage, glioblastoma multiforme. These results suggest a genetic approach to defining degrees of tumor progression and the locations of genes involved in the pathway as a prelude to their molecular isolation and characterization.

KW - Cancer, human progression of

KW - Cancer, human, predisposition to

KW - Genetics, molecular

UR - http://www.scopus.com/inward/record.url?scp=0025730459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025730459&partnerID=8YFLogxK

U2 - 10.1016/0027-5107(91)90015-G

DO - 10.1016/0027-5107(91)90015-G

M3 - Article

C2 - 2011137

AN - SCOPUS:0025730459

VL - 247

SP - 199

EP - 202

JO - Mutation Research

JF - Mutation Research

SN - 1386-1964

IS - 2

ER -